MEIRAGTX HLDGS PLC's ticker is MGTX and the CUSIP is G59665102. A total of 98 filers reported holding MEIRAGTX HLDGS PLC in Q3 2022. The put-call ratio across all filers is 1.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $121,000 | +12.0% | 14,362 | +0.7% | 0.05% | +20.0% |
| Q2 2022 | $108,000 | +2.9% | 14,264 | +88.2% | 0.04% | -14.9% |
| Q1 2022 | $105,000 | -45.0% | 7,579 | -5.6% | 0.05% | -34.7% |
| Q4 2021 | $191,000 | +3.2% | 8,032 | -42.7% | 0.07% | -11.1% |
| Q3 2021 | $185,000 | -18.9% | 14,007 | -4.9% | 0.08% | -13.8% |
| Q2 2021 | $228,000 | -31.7% | 14,736 | -36.4% | 0.09% | -33.3% |
| Q1 2021 | $334,000 | -3.2% | 23,179 | +1.8% | 0.14% | -1.4% |
| Q4 2020 | $345,000 | +11.7% | 22,763 | -2.5% | 0.14% | -11.7% |
| Q3 2020 | $309,000 | -6.9% | 23,357 | -12.0% | 0.16% | +3.2% |
| Q2 2020 | $332,000 | +44.3% | 26,545 | +55.1% | 0.16% | +65.3% |
| Q1 2020 | $230,000 | -41.3% | 17,114 | -12.7% | 0.10% | +48.4% |
| Q4 2019 | $392,000 | +100.0% | 19,596 | +59.2% | 0.06% | +64.1% |
| Q3 2019 | $196,000 | -43.8% | 12,311 | -5.3% | 0.04% | -47.3% |
| Q2 2019 | $349,000 | – | 12,997 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 2,898,550 | $38,957,000 | 21.20% |
| Prosight Management, LP | 568,348 | $7,639,000 | 3.57% |
| Perceptive Advisors | 6,433,277 | $86,463,000 | 2.25% |
| Orbimed Advisors | 3,582,320 | $48,146,000 | 0.81% |
| Parkman Healthcare Partners LLC | 125,000 | $1,680,000 | 0.78% |
| 683 Capital Management, LLC | 831,748 | $11,178,000 | 0.66% |
| Claraphi Advisory Network, LLC | 98,850 | $1,329,000 | 0.63% |
| Fort Sheridan Advisors LLC | 54,512 | $733,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 246,307 | $3,310,000 | 0.46% |
| PA Capital LLC | 39,039 | $525,000 | 0.46% |